Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Diagonal Bio

Less than 1K followers
Overview
Investor consensus
All
Press releases
ShowingAll content types
Regulatory press releaseyesterday

Diagonal Bio has been declared in bankruptcy

Diagonal Bio
Regulatory press releaseyesterday

Diagonal Bio intends to submit a formal application for bankruptcy

Diagonal Bio
Regulatory press release12/1/2025, 7:30 AM

Nomination Committee appointed for Diagonal Bio

Diagonal Bio

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/4/2025, 8:30 AM

Untersteiner Racing signs agreement for a pilot test

Diagonal Bio
Regulatory press release10/31/2025, 7:00 AM

Diagonal Bio publishes interim report for the third quarter of 2025

Diagonal Bio
Press release10/13/2025, 7:00 AM

Diagonal Bio launches new website to reflect commercial focus on the Animal Health segment

Diagonal Bio
Press release10/3/2025, 9:30 AM

Diagonal Bio initiates collaboration with SVA on evaluation of coronavirus in horses

Diagonal Bio
Regulatory press release9/23/2025, 9:15 AM

Diagonal Bio expands horse testing panel to detect Equine Herpesvirus type 2

Diagonal Bio
Regulatory press release9/18/2025, 11:00 AM

Diagonal Bio receives order from Stall Courant

Diagonal Bio
Regulatory press release8/22/2025, 6:00 AM

Diagonal Bio publishes interim report for the second quarter of 2025

Diagonal Bio
Press release8/20/2025, 6:00 AM

Diagonal Bio AB receives patent approval in Japan

Diagonal Bio
Press release7/7/2025, 11:00 AM

Diagonal Bio AB files patent application for Novel Computational Method that significantly improves LAMP primer design

Diagonal Bio
Regulatory press release6/25/2025, 11:00 AM

The Board of Directors of Diagonal Bio carries out a directed issue to underwriters in connection with exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release6/19/2025, 11:40 AM

Diagonal Bio receives SEK 3.6 million through exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release6/17/2025, 4:47 PM

Update regarding large shareholder’s exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release6/17/2025, 6:30 AM

Diagonal Bio expands equine panel with addition of strangles

Diagonal Bio
Regulatory press release6/16/2025, 6:30 AM

Large shareholder exercises warrants of series TO 2

Diagonal Bio
Regulatory press release6/13/2025, 6:00 AM

Last day of trading in Diagonal Bio’s warrants of series TO 2 is 16 June 2025

Diagonal Bio
Press release6/11/2025, 9:30 AM

Diagonal Bio shares progress update on LAMPlify® commercial pilots

Diagonal Bio
Regulatory press release6/9/2025, 12:00 PM

Svea Bank AB invests SEK 0.5 million in Diagonal Bio AB through the exercise of warrants of series TO 2

Diagonal Bio
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.